LDL Cholesterol and Cardiovascular Disease: The Causal Link

LDL cholesterol (LDL-C) is a primary causal driver of atherosclerotic cardiovascular disease (ASCVD).

Pathophysiology

  1. Elevated LDL-C → increased subendothelial retention of apoB-containing lipoproteins
  2. Oxidation/modification → pro-inflammatory response
  3. Monocyte recruitment → foam cell formation → fatty streak
  4. Fibrous cap formation → atherosclerotic plaque
  5. Plaque rupture/erosion → thrombosis → MI, stroke, limb ischemia

Evidence

  • Genetic (PCSK9, LDL-R variants): lifelong low LDL → markedly reduced CVD
  • Mendelian randomization: confirms causality
  • RCTs (statins, ezetimibe, PCSK9i): LDL lowering → proportional CVD risk reduction

Targets (ACC/AHA / ESC)

  • Very high risk: <55 mg/dL (<1.4 mmol/L) and ≥50% reduction
  • High risk: <70 mg/dL (<1.8 mmol/L)
  • Primary prevention: risk-based (ASCVD score)

Therapeutic lifestyle + statin ± ezetimibe/PCSK9i/bempedoic acid achieves goals.

Cardiovascular Disease - Related Articles